Philips and AWS collaborate to scale digital pathology in the cloud, enhancing diagnostic capabilities and improving productivity
- None.
- None.
The announcement of Royal Philips expanding its collaboration with Amazon Web Services (AWS) to enhance digital pathology solutions in the cloud represents a significant development in the healthcare technology sector. Digital pathology is a rapidly growing field that leverages digital imaging and data analysis to improve diagnostic accuracy and efficiency in pathology labs. This partnership underscores the increasing trend of healthcare moving towards cloud-based solutions, which offer scalability, security and improved data management capabilities.
From a technological perspective, Philips' use of AWS HealthImaging to optimize storage and enable AI research is poised to drive innovation in pathology image analysis. The integration of Amazon Bedrock for developing generative AI applications could potentially revolutionize how pathologists interact with tissue sample data, enabling more sophisticated diagnostic tools. As AI and machine learning continue to advance, the ability to process and analyze large datasets in the cloud becomes increasingly crucial for developing predictive models and personalized medicine strategies.
For healthcare providers and institutions, the shift to cloud-based digital pathology could lead to enhanced collaboration among specialists and integration with other healthcare systems, providing a more holistic approach to patient care. This could translate into improved patient outcomes, more efficient workflows and potentially lower costs due to reduced reliance on physical storage and on-premise infrastructure.
Philips' collaboration with AWS reflects a strategic move to capture a larger share of the digital pathology market, which is expected to grow significantly in the coming years. By leveraging AWS's cloud infrastructure, Philips is positioning itself to meet the increasing demand for digital pathology services, which is driven by the growing need for efficient diagnostic solutions in the face of rising chronic diseases, such as cancer.
The partnership could also open new revenue streams for Philips through the facilitation of large-scale clinical trials and multi-institute studies. By offering a cloud-based solution that can handle the growing volume of digital pathology data, Philips is likely to attract more customers, including research institutions and healthcare providers looking for scalable and secure data management solutions.
Investors and stakeholders in the healthcare technology and cloud services sectors may view this collaboration as a positive indicator of Philips' commitment to innovation and growth. The company's ability to offer integrated solutions that combine clinical workflow optimization with advanced cloud technology could enhance its competitive edge and market position.
The utilization of AWS's cloud technology in Philips' digital pathology solutions has implications for the future of medical research and diagnostics. Digital pathology, as a cornerstone in the diagnosis and management of diseases, especially cancer, relies heavily on the analysis of tissue samples. Cloud-based storage and AI-powered analysis tools can significantly expedite the diagnostic process and improve the accuracy of disease characterization.
Furthermore, the ability to store vast amounts of digital pathology data securely in the cloud facilitates more comprehensive and longitudinal studies, which are essential for understanding disease progression and treatment outcomes. The accessibility of this data can also enhance collaborative research efforts across institutions, leading to more robust and diverse datasets that can inform clinical trials and medical research.
The integration of cloud-based digital pathology with other healthcare systems can lead to more data-driven approaches to patient care, potentially enabling the development of new diagnostic biomarkers and therapeutic strategies. This integrated approach is particularly relevant in oncology, where precision medicine and individualized treatment plans are becoming increasingly important.
March 12, 2024
- Cloud offering will help improve workflow integration, access, and reliability, delivering greater productivity and collaboration
- Collaboration combines best of clinical workflow leadership with scalable cloud solution to help accelerate decision-making and further transform patient care
Amsterdam, the Netherlands and Orlando, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an expanded collaboration with Amazon Web Services (AWS) to address the growing need for secure, scalable digital pathology solutions in the cloud. The collaboration unites Philips’ leadership and expertise in digitization of pathology to optimize clinical workflows and AWS’ leadership in scalable, secure cloud solutions.
Philips and AWS will advance digital pathology and help pathology labs to efficiently store, manage, and analyze growing volumes of digital pathology data and enable more pathology labs to adopt digital workflows to increase productivity. In addition, pathology labs will be able to optimize workflow efficiency and facilitate collaboration among specialists, enabling seamless integration with existing healthcare systems to deliver holistic patient care.
Through examination of patient tissue samples, pathology plays a crucial role in the diagnosis and management of a variety of diseases, particularly cancer. With an estimated
“By harnessing the power of the cloud to accelerate the digitization of pathology, we are improving the quality of patient care by enabling greater workflow efficiency and collaboration at scale,” said Shez Partovi, Chief Innovation & Strategy Officer and Chief Business Leader Enterprise Informatics at Philips. “As the demand for pathology-based diagnosis continues to increase, we see digital pathology in the cloud as a critical enabler for productivity, scale and to further transform healthcare diagnostics by opening new avenues for research, education, and the integration of AI to further improve patient care.”
Philips is an industry-leading provider of digital pathology solutions, with more than 300 customers using the fully digital workflow of Philips IntelliSite Pathology. Philips’ collaboration with AWS has the potential to enable large scale clinical trials, multi-institute studies, and care collaboration to address complex cases, including in cancer care. Philips will use AWS HealthImaging to optimize storage, increase scale and enable AI and research across the healthcare system to advance pathology image analysis and simplify clinical workflows. Additionally, Amazon Bedrock, which offers high-performing foundation models (FMs), will support generative AI application development and integration.
“Healthcare organizations benefit when clinical workflow leadership is combined with scalable cloud infrastructure. By building their cloud-native enterprise pathology solution on services like AWS HealthImaging and Amazon Bedrock, Philips is offering their customers the best of both worlds,” said Tehsin Syed, GM of Health AI at AWS. “Secure cloud-based offerings address the growing demand to store and utilize more data, and by digitizing pathology healthcare leaders can apply AI and ML to drive better insights. We look forward to continued work with Philips to help improve productivity, advance research, and ultimately enable more precise and tailored patient care.”
Combined with Philips HealthSuite Imaging on AWS to support radiologists, Philips’ broad capabilities in enterprise informatics enable an integrated diagnostics approach to empower clinicians with improved diagnostic workflows, quicker access to images from any location – helping along the entire workflow across enterprise imaging, from diagnosis to treatment options and follow-up.
For more information on Philips’ informatics solutions and news at HIMSS, please visit here or join us in person at the HIMSS 2024 conference, booth #2041 and follow #HIMSS24 for updates.
[1] Report of the Second Phase of the Review of NHS Pathology Services in England, Lord Carter of Coles (2008). Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.
For further information, please contact:
Anna Hogrebe
Philips External Relations
Tel.: +1 416 270 6757
E-mail: anna.hogrebe@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring, and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachments
FAQ
What is the purpose of the collaboration between Royal Philips and Amazon Web Services?
How does Philips plan to improve patient care through this collaboration?
What role does digital pathology play in the diagnosis and management of diseases?
What benefits do healthcare organizations gain from combining clinical workflow leadership with scalable cloud infrastructure?
How does the collaboration between Philips and AWS support pathology image analysis?
